دورية أكاديمية
Regorafenib dose-optimisation in patients with refractory metastatic colorectal cancer (ReDOS): a randomised, multicentre, open-label, phase 2 study
| العنوان: | Regorafenib dose-optimisation in patients with refractory metastatic colorectal cancer (ReDOS): a randomised, multicentre, open-label, phase 2 study |
|---|---|
| المؤلفون: | Bekaii-Saab, Tanios S, Ou, Fang-Shu, Ahn, Daniel H, Boland, Patrick M, Ciombor, Kristen K, Heying, Erica N, Dockter, Travis J, Jacobs, Nisha L, Pasche, Boris C, Cleary, James M, Meyers, Jeffrey P, Desnoyers, Rodwige J, McCune, Jeannine S, Pedersen, Katrina, Barzi, Afsaneh, Chiorean, E Gabriela, Sloan, Jeffrey, Lacouture, Mario E, Lenz, Heinz-Josef, Grothey, Axel |
| المصدر: | The Lancet Oncology ; volume 20, issue 8, page 1070-1082 ; ISSN 1470-2045 |
| بيانات النشر: | Elsevier BV |
| سنة النشر: | 2019 |
| المجموعة: | ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| مصطلحات موضوعية: | Oncology |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| DOI: | 10.1016/s1470-2045(19)30272-4 |
| الإتاحة: | https://doi.org/10.1016/s1470-2045Test(19)30272-4 https://api.elsevier.com/content/article/PII:S1470204519302724?httpAccept=text/xmlTest https://api.elsevier.com/content/article/PII:S1470204519302724?httpAccept=text/plainTest |
| حقوق: | https://www.elsevier.com/tdm/userlicense/1.0Test/ |
| رقم الانضمام: | edsbas.D24FBA89 |
| قاعدة البيانات: | BASE |
| DOI: | 10.1016/s1470-2045(19)30272-4 |
|---|